YH, Y., HJ, H., TW, H., TY, L., JD, Y., G, C., . . . CY, W. (2026). Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort Study. Liver cancer. https://doi.org/10.1159/000550360
Chicago Style (17th ed.) CitationYH, Yeo, et al. "Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort Study." Liver Cancer 2026. https://doi.org/10.1159/000550360.
MLA (9th ed.) CitationYH, Yeo, et al. "Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort Study." Liver Cancer, 2026, https://doi.org/10.1159/000550360.
Warning: These citations may not always be 100% accurate.